Listed

TELA Bio, Inc.

TELANasdaqCIK 1561921HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$19.3m, Q2 FY2026
Operating income−$9.3m, Q2 FY2026
Net income−$11.3m, Q2 FY2026
TELA Bio, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m15.1Revenue, Q3 FY2023, three months to 2023-09-30$15.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-08, accession 0001558370-24-015050.Report this figure17.0Revenue, Q4 FY2023, three months to 2023-12-31$17.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-25, accession 0001104659-26-034507. Derived: 12-month figure less the 9-month figure.Report this figure16.6Revenue, Q1 FY2024, three months to 2024-03-31$16.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-08, accession 0001558370-25-006994.Report this figure16.1Revenue, Q2 FY2024, three months to 2024-06-30$16.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-11, accession 0001558370-25-011052.Report this figure19.0Revenue, Q3 FY2024, three months to 2024-09-30$19.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-14, accession 0001104659-25-112476.Report this figure17.6Revenue, Q4 FY2024, three months to 2024-12-31$17.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-25, accession 0001104659-26-034507. Derived: 12-month figure less the 9-month figure.Report this figure18.5Revenue, Q1 FY2025, three months to 2025-03-31$18.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001104659-26-060234.Report this figure20.2Revenue, Q2 FY2025, three months to 2025-06-30$20.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-11, accession 0001104659-26-094039.Report this figure20.7Revenue, Q3 FY2025, three months to 2025-09-30$20.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-14, accession 0001104659-25-112476.Report this figure20.9Revenue, Q4 FY2025, three months to 2025-12-31$20.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-25, accession 0001104659-26-034507. Derived: 12-month figure less the 9-month figure.Report this figure19.1Revenue, Q1 FY2026, three months to 2026-03-31$19.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001104659-26-060234.Report this figure19.3Revenue, Q2 FY2026, three months to 2026-06-30$19.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-11, accession 0001104659-26-094039.Report this figure
Gross profit$m10.4Gross profit, Q3 FY2023, three months to 2023-09-30$10.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-11-08, accession 0001558370-24-015050.Report this figure11.6Gross profit, Q4 FY2023, three months to 2023-12-31$11.6m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-25, accession 0001104659-26-034507. Derived: 12-month figure less the 9-month figure.Report this figure11.3Gross profit, Q1 FY2024, three months to 2024-03-31$11.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-05-08, accession 0001558370-25-006994.Report this figure11.1Gross profit, Q2 FY2024, three months to 2024-06-30$11.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-08-11, accession 0001558370-25-011052.Report this figure12.9Gross profit, Q3 FY2024, three months to 2024-09-30$12.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-14, accession 0001104659-25-112476.Report this figure11.2Gross profit, Q4 FY2024, three months to 2024-12-31$11.2m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-25, accession 0001104659-26-034507. Derived: 12-month figure less the 9-month figure.Report this figure12.5Gross profit, Q1 FY2025, three months to 2025-03-31$12.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-13, accession 0001104659-26-060234.Report this figure14.1Gross profit, Q2 FY2025, three months to 2025-06-30$14.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-11, accession 0001104659-26-094039.Report this figure14.0Gross profit, Q3 FY2025, three months to 2025-09-30$14.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-14, accession 0001104659-25-112476.Report this figure13.8Gross profit, Q4 FY2025, three months to 2025-12-31$13.8m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-25, accession 0001104659-26-034507. Derived: 12-month figure less the 9-month figure.Report this figure12.5Gross profit, Q1 FY2026, three months to 2026-03-31$12.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-13, accession 0001104659-26-060234.Report this figure13.9Gross profit, Q2 FY2026, three months to 2026-06-30$13.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-11, accession 0001104659-26-094039.Report this figure
Research and development$m2.4Research and development, Q3 FY2023, three months to 2023-09-30$2.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-08, accession 0001558370-24-015050.Report this figure2.7Research and development, Q4 FY2023, three months to 2023-12-31$2.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-25, accession 0001104659-26-034507. Derived: 12-month figure less the 9-month figure.Report this figure2.4Research and development, Q1 FY2024, three months to 2024-03-31$2.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-08, accession 0001558370-25-006994.Report this figure2.3Research and development, Q2 FY2024, three months to 2024-06-30$2.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-11, accession 0001558370-25-011052.Report this figure2.1Research and development, Q3 FY2024, three months to 2024-09-30$2.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-14, accession 0001104659-25-112476.Report this figure2.0Research and development, Q4 FY2024, three months to 2024-12-31$2.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-25, accession 0001104659-26-034507. Derived: 12-month figure less the 9-month figure.Report this figure2.5Research and development, Q1 FY2025, three months to 2025-03-31$2.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001104659-26-060234.Report this figure2.2Research and development, Q2 FY2025, three months to 2025-06-30$2.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-11, accession 0001104659-26-094039.Report this figure2.3Research and development, Q3 FY2025, three months to 2025-09-30$2.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-14, accession 0001104659-25-112476.Report this figure2.1Research and development, Q4 FY2025, three months to 2025-12-31$2.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-25, accession 0001104659-26-034507. Derived: 12-month figure less the 9-month figure.Report this figure2.3Research and development, Q1 FY2026, three months to 2026-03-31$2.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001104659-26-060234.Report this figure2.7Research and development, Q2 FY2026, three months to 2026-06-30$2.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-11, accession 0001104659-26-094039.Report this figure
Operating income$m(10.2)Operating income, Q3 FY2023, three months to 2023-09-30−$10.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-08, accession 0001558370-24-015050.Report this figure(12.3)Operating income, Q4 FY2023, three months to 2023-12-31−$12.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-25, accession 0001104659-26-034507. Derived: 12-month figure less the 9-month figure.Report this figure(4.8)Operating income, Q1 FY2024, three months to 2024-03-31−$4.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-08, accession 0001558370-25-006994.Report this figure(11.6)Operating income, Q2 FY2024, three months to 2024-06-30−$11.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-11, accession 0001558370-25-011052.Report this figure(9.4)Operating income, Q3 FY2024, three months to 2024-09-30−$9.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-14, accession 0001104659-25-112476.Report this figure(8.4)Operating income, Q4 FY2024, three months to 2024-12-31−$8.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-25, accession 0001104659-26-034507. Derived: 12-month figure less the 9-month figure.Report this figure(10.5)Operating income, Q1 FY2025, three months to 2025-03-31−$10.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001104659-26-060234.Report this figure(9.1)Operating income, Q2 FY2025, three months to 2025-06-30−$9.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001104659-26-094039.Report this figure(7.6)Operating income, Q3 FY2025, three months to 2025-09-30−$7.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-14, accession 0001104659-25-112476.Report this figure(6.6)Operating income, Q4 FY2025, three months to 2025-12-31−$6.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-25, accession 0001104659-26-034507. Derived: 12-month figure less the 9-month figure.Report this figure(10.5)Operating income, Q1 FY2026, three months to 2026-03-31−$10.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001104659-26-060234.Report this figure(9.3)Operating income, Q2 FY2026, three months to 2026-06-30−$9.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001104659-26-094039.Report this figure
Interest expense$m1.3Interest expense, Q3 FY2023, three months to 2023-09-30$1.3m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-13, accession 0001558370-23-018822.Report this figure1.3Interest expense, Q4 FY2023, three months to 2023-12-31$1.3m. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-03-22, accession 0001558370-24-003782. Derived: 12-month figure less the 9-month figure.Report this figure1.3Interest expense, Q1 FY2024, three months to 2024-03-31$1.3m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-10, accession 0001558370-24-007784.Report this figure1.3Interest expense, Q2 FY2024, three months to 2024-06-30$1.3m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-08-11, accession 0001558370-25-011052.Report this figure1.3Interest expense, Q3 FY2024, three months to 2024-09-30$1.3m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-14, accession 0001104659-25-112476.Report this figure1.3Interest expense, Q4 FY2024, three months to 2024-12-31$1.3m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-25, accession 0001104659-26-034507. Derived: 12-month figure less the 9-month figure.Report this figure1.2Interest expense, Q1 FY2025, three months to 2025-03-31$1.2m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-13, accession 0001104659-26-060234.Report this figure1.2Interest expense, Q2 FY2025, three months to 2025-06-30$1.2m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-11, accession 0001104659-26-094039.Report this figure1.2Interest expense, Q3 FY2025, three months to 2025-09-30$1.2m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-14, accession 0001104659-25-112476.Report this figure1.6Interest expense, Q4 FY2025, three months to 2025-12-31$1.6m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-25, accession 0001104659-26-034507. Derived: 12-month figure less the 9-month figure.Report this figure2.1Interest expense, Q1 FY2026, three months to 2026-03-31$2.1m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-13, accession 0001104659-26-060234.Report this figure2.1Interest expense, Q2 FY2026, three months to 2026-06-30$2.1m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-11, accession 0001104659-26-094039.Report this figure
Income tax$mnot reportednot reportednot reportednot reportednot reportednot reported0.1Income tax, Q1 FY2025, three months to 2025-03-31$52.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-13, accession 0001104659-26-060234.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$33.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-11, accession 0001104659-26-094039.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-14, accession 0001104659-25-112476. Derived: 9-month figure less the 6-month figure.Report this figure0.1Income tax, Q4 FY2025, three months to 2025-12-31$145.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-25, accession 0001104659-26-034507. Derived: 12-month figure less the 9-month figure.Report this figure0.1Income tax, Q1 FY2026, three months to 2026-03-31$60.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-13, accession 0001104659-26-060234.Report this figure0.1Income tax, Q2 FY2026, three months to 2026-06-30$60.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-11, accession 0001104659-26-094039.Report this figure
Net income$m(11.0)Net income, Q3 FY2023, three months to 2023-09-30−$11.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-08, accession 0001558370-24-015050.Report this figure(12.9)Net income, Q4 FY2023, three months to 2023-12-31−$12.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-25, accession 0001104659-26-034507. Derived: 12-month figure less the 9-month figure.Report this figure(5.7)Net income, Q1 FY2024, three months to 2024-03-31−$5.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-08, accession 0001558370-25-006994.Report this figure(12.6)Net income, Q2 FY2024, three months to 2024-06-30−$12.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-11, accession 0001558370-25-011052.Report this figure(10.4)Net income, Q3 FY2024, three months to 2024-09-30−$10.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-14, accession 0001104659-25-112476.Report this figure(9.2)Net income, Q4 FY2024, three months to 2024-12-31−$9.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-25, accession 0001104659-26-034507. Derived: 12-month figure less the 9-month figure.Report this figure(11.3)Net income, Q1 FY2025, three months to 2025-03-31−$11.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-13, accession 0001104659-26-060234.Report this figure(9.9)Net income, Q2 FY2025, three months to 2025-06-30−$9.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001104659-26-094039.Report this figure(8.6)Net income, Q3 FY2025, three months to 2025-09-30−$8.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-14, accession 0001104659-25-112476.Report this figure(9.0)Net income, Q4 FY2025, three months to 2025-12-31−$9.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-25, accession 0001104659-26-034507. Derived: 12-month figure less the 9-month figure.Report this figure(12.3)Net income, Q1 FY2026, three months to 2026-03-31−$12.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-13, accession 0001104659-26-060234.Report this figure(11.3)Net income, Q2 FY2026, three months to 2026-06-30−$11.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001104659-26-094039.Report this figure
Diluted EPS$ per share(0.45)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.45 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-08, accession 0001558370-24-015050.Report this figurenot reported(0.23)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.23 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-08, accession 0001558370-25-006994.Report this figure(0.51)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.51 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-11, accession 0001558370-25-011052.Report this figure(0.42)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.42 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-14, accession 0001104659-25-112476.Report this figurenot reported(0.25)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.25 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001104659-26-060234.Report this figure(0.22)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.22 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001104659-26-094039.Report this figure(0.19)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-14, accession 0001104659-25-112476.Report this figurenot reported(0.21)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.21 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001104659-26-060234.Report this figure(0.20)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.20 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001104659-26-094039.Report this figure
Basic EPS$ per share(0.45)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.45 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-08, accession 0001558370-24-015050.Report this figurenot reported(0.23)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.23 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-08, accession 0001558370-25-006994.Report this figure(0.51)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.51 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-11, accession 0001558370-25-011052.Report this figure(0.42)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.42 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-14, accession 0001104659-25-112476.Report this figurenot reported(0.25)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.25 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001104659-26-060234.Report this figure(0.22)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.22 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-11, accession 0001104659-26-094039.Report this figure(0.19)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.19 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-14, accession 0001104659-25-112476.Report this figurenot reported(0.21)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.21 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001104659-26-060234.Report this figure(0.20)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.20 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-11, accession 0001104659-26-094039.Report this figure

Balance sheet

Cash and equivalents$30.4m, Q2 FY2026
Long-term debt$56.1m, Q2 FY2026
Shareholders' equity−$15.9m, Q2 FY2026
TELA Bio, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m58.2Cash and equivalents, Q3 FY2023, at 2023-09-30$58.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-13, accession 0001558370-23-018822.Report this figure46.7Cash and equivalents, FY2023, at 2023-12-31$46.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-21, accession 0001558370-25-003460.Report this figure37.1Cash and equivalents, Q1 FY2024, at 2024-03-31$37.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-08, accession 0001558370-25-006994.Report this figure26.5Cash and equivalents, Q2 FY2024, at 2024-06-30$26.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-11, accession 0001558370-25-011052.Report this figure17.3Cash and equivalents, Q3 FY2024, at 2024-09-30$17.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-14, accession 0001104659-25-112476.Report this figure52.7Cash and equivalents, FY2024, at 2024-12-31$52.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-25, accession 0001104659-26-034507.Report this figure42.8Cash and equivalents, Q1 FY2025, at 2025-03-31$42.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-13, accession 0001104659-26-060234.Report this figure35.0Cash and equivalents, Q2 FY2025, at 2025-06-30$35.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001104659-26-094039.Report this figure29.7Cash and equivalents, Q3 FY2025, at 2025-09-30$29.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-14, accession 0001104659-25-112476.Report this figure50.8Cash and equivalents, FY2025, at 2025-12-31$50.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001104659-26-094039.Report this figure39.5Cash and equivalents, Q1 FY2026, at 2026-03-31$39.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-13, accession 0001104659-26-060234.Report this figure30.4Cash and equivalents, Q2 FY2026, at 2026-06-30$30.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001104659-26-094039.Report this figure
Current assets$m82.3Current assets, Q3 FY2023, at 2023-09-30$82.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-13, accession 0001558370-23-018822.Report this figure71.7Current assets, FY2023, at 2023-12-31$71.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-21, accession 0001558370-25-003460.Report this figure62.6Current assets, Q1 FY2024, at 2024-03-31$62.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-10, accession 0001558370-24-007784.Report this figure51.1Current assets, Q2 FY2024, at 2024-06-30$51.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-13, accession 0001558370-24-012060.Report this figure44.1Current assets, Q3 FY2024, at 2024-09-30$44.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-08, accession 0001558370-24-015050.Report this figure78.1Current assets, FY2024, at 2024-12-31$78.1m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-25, accession 0001104659-26-034507.Report this figure69.7Current assets, Q1 FY2025, at 2025-03-31$69.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-08, accession 0001558370-25-006994.Report this figure60.7Current assets, Q2 FY2025, at 2025-06-30$60.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-11, accession 0001558370-25-011052.Report this figure56.0Current assets, Q3 FY2025, at 2025-09-30$56.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-14, accession 0001104659-25-112476.Report this figure75.6Current assets, FY2025, at 2025-12-31$75.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-11, accession 0001104659-26-094039.Report this figure64.3Current assets, Q1 FY2026, at 2026-03-31$64.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-13, accession 0001104659-26-060234.Report this figure54.5Current assets, Q2 FY2026, at 2026-06-30$54.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-11, accession 0001104659-26-094039.Report this figure
Total assets$m87.3Total assets, Q3 FY2023, at 2023-09-30$87.3m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-13, accession 0001558370-23-018822.Report this figure78.0Total assets, FY2023, at 2023-12-31$78.0m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-21, accession 0001558370-25-003460.Report this figure71.8Total assets, Q1 FY2024, at 2024-03-31$71.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-10, accession 0001558370-24-007784.Report this figure60.2Total assets, Q2 FY2024, at 2024-06-30$60.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-13, accession 0001558370-24-012060.Report this figure53.0Total assets, Q3 FY2024, at 2024-09-30$53.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-08, accession 0001558370-24-015050.Report this figure86.6Total assets, FY2024, at 2024-12-31$86.6m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-25, accession 0001104659-26-034507.Report this figure77.3Total assets, Q1 FY2025, at 2025-03-31$77.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-08, accession 0001558370-25-006994.Report this figure67.5Total assets, Q2 FY2025, at 2025-06-30$67.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-11, accession 0001558370-25-011052.Report this figure61.6Total assets, Q3 FY2025, at 2025-09-30$61.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-14, accession 0001104659-25-112476.Report this figure81.4Total assets, FY2025, at 2025-12-31$81.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-11, accession 0001104659-26-094039.Report this figure69.9Total assets, Q1 FY2026, at 2026-03-31$69.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-13, accession 0001104659-26-060234.Report this figure59.7Total assets, Q2 FY2026, at 2026-06-30$59.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-11, accession 0001104659-26-094039.Report this figure
Current liabilities$m15.3Current liabilities, Q3 FY2023, at 2023-09-30$15.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-13, accession 0001558370-23-018822.Report this figure17.0Current liabilities, FY2023, at 2023-12-31$17.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-21, accession 0001558370-25-003460.Report this figure15.2Current liabilities, Q1 FY2024, at 2024-03-31$15.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-10, accession 0001558370-24-007784.Report this figure15.0Current liabilities, Q2 FY2024, at 2024-06-30$15.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-13, accession 0001558370-24-012060.Report this figure16.9Current liabilities, Q3 FY2024, at 2024-09-30$16.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-08, accession 0001558370-24-015050.Report this figure15.6Current liabilities, FY2024, at 2024-12-31$15.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-25, accession 0001104659-26-034507.Report this figure16.5Current liabilities, Q1 FY2025, at 2025-03-31$16.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-08, accession 0001558370-25-006994.Report this figure19.1Current liabilities, Q2 FY2025, at 2025-06-30$19.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-11, accession 0001558370-25-011052.Report this figure17.0Current liabilities, Q3 FY2025, at 2025-09-30$17.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-14, accession 0001104659-25-112476.Report this figure18.0Current liabilities, FY2025, at 2025-12-31$18.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-11, accession 0001104659-26-094039.Report this figure17.8Current liabilities, Q1 FY2026, at 2026-03-31$17.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-13, accession 0001104659-26-060234.Report this figure18.2Current liabilities, Q2 FY2026, at 2026-06-30$18.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-11, accession 0001104659-26-094039.Report this figure
Total liabilities$m56.8Total liabilities, Q3 FY2023, at 2023-09-30$56.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-13, accession 0001558370-23-018822.Report this figure59.2Total liabilities, FY2023, at 2023-12-31$59.2m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-21, accession 0001558370-25-003460.Report this figure57.5Total liabilities, Q1 FY2024, at 2024-03-31$57.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-10, accession 0001558370-24-007784.Report this figure57.3Total liabilities, Q2 FY2024, at 2024-06-30$57.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-13, accession 0001558370-24-012060.Report this figure59.3Total liabilities, Q3 FY2024, at 2024-09-30$59.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-08, accession 0001558370-24-015050.Report this figure58.1Total liabilities, FY2024, at 2024-12-31$58.1m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-25, accession 0001104659-26-034507.Report this figure59.1Total liabilities, Q1 FY2025, at 2025-03-31$59.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-08, accession 0001558370-25-006994.Report this figure58.4Total liabilities, Q2 FY2025, at 2025-06-30$58.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-11, accession 0001558370-25-011052.Report this figure60.0Total liabilities, Q3 FY2025, at 2025-09-30$60.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-14, accession 0001104659-25-112476.Report this figure75.1Total liabilities, FY2025, at 2025-12-31$75.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-11, accession 0001104659-26-094039.Report this figure75.1Total liabilities, Q1 FY2026, at 2026-03-31$75.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-13, accession 0001104659-26-060234.Report this figure75.6Total liabilities, Q2 FY2026, at 2026-06-30$75.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-11, accession 0001104659-26-094039.Report this figure
Long-term debt$m40.4Long-term debt, Q3 FY2023, at 2023-09-30$40.4m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2023-11-13, accession 0001558370-23-018822.Report this figure40.5Long-term debt, FY2023, at 2023-12-31$40.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-03-21, accession 0001558370-25-003460.Report this figure40.7Long-term debt, Q1 FY2024, at 2024-03-31$40.7m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-05-10, accession 0001558370-24-007784.Report this figure40.8Long-term debt, Q2 FY2024, at 2024-06-30$40.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-08-13, accession 0001558370-24-012060.Report this figure41.0Long-term debt, Q3 FY2024, at 2024-09-30$41.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-11-08, accession 0001558370-24-015050.Report this figure41.1Long-term debt, FY2024, at 2024-12-31$41.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-03-25, accession 0001104659-26-034507.Report this figure41.3Long-term debt, Q1 FY2025, at 2025-03-31$41.3m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-05-08, accession 0001558370-25-006994.Report this figure38.1Long-term debt, Q2 FY2025, at 2025-06-30$38.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-08-11, accession 0001558370-25-011052.Report this figure41.5Long-term debt, Q3 FY2025, at 2025-09-30$41.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-11-14, accession 0001104659-25-112476.Report this figure55.7Long-term debt, FY2025, at 2025-12-31$55.7m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-11, accession 0001104659-26-094039.Report this figure55.9Long-term debt, Q1 FY2026, at 2026-03-31$55.9m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-05-13, accession 0001104659-26-060234.Report this figure56.1Long-term debt, Q2 FY2026, at 2026-06-30$56.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-11, accession 0001104659-26-094039.Report this figure
Current portion of debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reported3.3Current portion of debt, Q2 FY2025, at 2025-06-30$3.3m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-08-11, accession 0001558370-25-011052.Report this figurenot reportednot reportednot reportednot reported
Shareholders' equity$m30.6Shareholders' equity, Q3 FY2023, at 2023-09-30$30.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-08, accession 0001558370-24-015050.Report this figure18.9Shareholders' equity, FY2023, at 2023-12-31$18.9m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-25, accession 0001104659-26-034507.Report this figure14.4Shareholders' equity, Q1 FY2024, at 2024-03-31$14.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-11, accession 0001558370-25-011052.Report this figure2.9Shareholders' equity, Q2 FY2024, at 2024-06-30$2.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-14, accession 0001104659-25-112476.Report this figure(6.3)Shareholders' equity, Q3 FY2024, at 2024-09-30−$6.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-14, accession 0001104659-25-112476.Report this figure28.5Shareholders' equity, FY2024, at 2024-12-31$28.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001104659-26-094039.Report this figure18.1Shareholders' equity, Q1 FY2025, at 2025-03-31$18.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001104659-26-094039.Report this figure9.2Shareholders' equity, Q2 FY2025, at 2025-06-30$9.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001104659-26-094039.Report this figure1.6Shareholders' equity, Q3 FY2025, at 2025-09-30$1.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-14, accession 0001104659-25-112476.Report this figure6.3Shareholders' equity, FY2025, at 2025-12-31$6.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001104659-26-094039.Report this figure(5.2)Shareholders' equity, Q1 FY2026, at 2026-03-31−$5.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001104659-26-094039.Report this figure(15.9)Shareholders' equity, Q2 FY2026, at 2026-06-30−$15.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001104659-26-094039.Report this figure

Cash flow

Operating cash flow−$9.4m, Q2 FY2026
Capital expenditure$59.0k, Q2 FY2026
TELA Bio, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(7.0)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$7.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-08, accession 0001558370-24-015050. Derived: 9-month figure less the 6-month figure.Report this figure(11.1)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$11.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-25, accession 0001104659-26-034507. Derived: 12-month figure less the 9-month figure.Report this figure(14.4)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$14.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-08, accession 0001558370-25-006994.Report this figure(10.7)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$10.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-11, accession 0001558370-25-011052. Derived: 6-month figure less the 3-month figure.Report this figure(9.0)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$9.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-14, accession 0001104659-25-112476. Derived: 9-month figure less the 6-month figure.Report this figure(7.5)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$7.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-25, accession 0001104659-26-034507. Derived: 12-month figure less the 9-month figure.Report this figure(9.7)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$9.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001104659-26-060234.Report this figure(7.9)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$7.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001104659-26-094039. Derived: 6-month figure less the 3-month figure.Report this figure(5.7)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$5.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-14, accession 0001104659-25-112476. Derived: 9-month figure less the 6-month figure.Report this figure(4.9)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$4.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-25, accession 0001104659-26-034507. Derived: 12-month figure less the 9-month figure.Report this figure(11.2)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$11.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001104659-26-060234.Report this figure(9.4)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$9.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001104659-26-094039. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.1Capital expenditure, Q3 FY2023, three months to 2023-09-30$134.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-08, accession 0001558370-24-015050. Derived: 9-month figure less the 6-month figure.Report this figure0.2Capital expenditure, Q4 FY2023, three months to 2023-12-31$205.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-25, accession 0001104659-26-034507. Derived: 12-month figure less the 9-month figure.Report this figure0.3Capital expenditure, Q1 FY2024, three months to 2024-03-31$304.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-08, accession 0001558370-25-006994.Report this figure0.3Capital expenditure, Q2 FY2024, three months to 2024-06-30$299.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-11, accession 0001558370-25-011052. Derived: 6-month figure less the 3-month figure.Report this figure0.1Capital expenditure, Q3 FY2024, three months to 2024-09-30$122.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-14, accession 0001104659-25-112476. Derived: 9-month figure less the 6-month figure.Report this figure0.3Capital expenditure, Q4 FY2024, three months to 2024-12-31$264.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-25, accession 0001104659-26-034507. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$32.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001104659-26-060234.Report this figure0.1Capital expenditure, Q2 FY2025, three months to 2025-06-30$114.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-11, accession 0001104659-26-094039. Derived: 6-month figure less the 3-month figure.Report this figure0.2Capital expenditure, Q3 FY2025, three months to 2025-09-30$211.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-14, accession 0001104659-25-112476. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2025, three months to 2025-12-31$91.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-25, accession 0001104659-26-034507. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2026, three months to 2026-03-31$119.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001104659-26-060234.Report this figure0.1Capital expenditure, Q2 FY2026, three months to 2026-06-30$59.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-11, accession 0001104659-26-094039. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)57.41m, Q2 FY2026
TELA Bio, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares16.8Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3016,758,573 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-13, accession 0001558370-23-018822.Report this figure19.2Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3119,185,621 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-10, accession 0001558370-24-007784.Report this figure23.2Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3023,239,262 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-13, accession 0001558370-24-012060.Report this figure24.5Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3024,483,664 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-08, accession 0001558370-24-015050.Report this figure24.6Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3124,579,386 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-08, accession 0001558370-25-006994.Report this figure24.7Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3024,663,234 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-11, accession 0001558370-25-011052.Report this figure24.7Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3024,703,578 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-14, accession 0001104659-25-112476.Report this figure45.3Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3145,267,020 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-13, accession 0001104659-26-060234.Report this figure45.4Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3045,365,325 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-11, accession 0001104659-26-094039.Report this figure45.4Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3045,421,795 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-14, accession 0001104659-25-112476.Report this figure57.3Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3157,256,518 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-13, accession 0001104659-26-060234.Report this figure57.4Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3057,414,360 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-11, accession 0001104659-26-094039.Report this figure

Shares outstanding: 44.89mShares outstanding, period not labelled, at 2026-08-0544,894,757 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-11, accession 0001104659-26-094039.Report this figure at Aug 5, 2026, from the cover of the 10-Q filed Aug 11, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. Listed shows no prices and gives no investment advice.